Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 2/20 | 0.43 |
| ▸ | CA5A | P35218 | 2/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12319214 | 0.82 | SMN1; SMN2 (0.43) | ALDH1A1SMN1; SMN2POLBKMT2ATSHR | |
| SCHEMBL2408985 | 0.82 | SMN1; SMN2 (0.43) | ALDH1A1SMN1; SMN2POLBKMT2ATSHR | |
| SCHEMBL9030133 | 0.81 | CA3 (0.60) | ALDH1A1SMN1; SMN2POLBKMT2AMEN1 | |
| SCHEMBL28659651 | 0.80 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2KMT2AMEN1TSHR | |
| SCHEMBL18262004 | 0.80 | ALDH1A1 (0.54) | ALDH1A1SMN1; SMN2POLBKMT2AMEN1 | |
| SCHEMBL18262005 | 0.80 | ALDH1A1 (0.54) | ALDH1A1SMN1; SMN2POLBKMT2AMEN1 | |
| SCHEMBL29067006 | 0.79 | TSHR (0.41) | ALDH1A1SMN1; SMN2KMT2ATSHRMAPT | |
| SCHEMBL9340830 | 0.78 | CA3 (0.56) | ALDH1A1SMN1; SMN2POLBKMT2AMEN1 | |
| SCHEMBL6834542 | 0.77 | CA2 (0.37) | ALDH1A1SMN1; SMN2POLBKMT2AMEN1 | |
| SCHEMBL9430552 | 0.77 | ALDH1A1 (0.58) | ALDH1A1SMN1; SMN2POLBKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 324 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112480902-B | Intelligent encapsulated acid and use method thereof | 四川省帕提科斯能源科技有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-112300773-B | Intelligent encapsulated oxidant and application method thereof | 西南石油大学 | 2023-03-28 | — | — | CN | claimed |
| CN-112480902-A | Intelligent encapsulated acid and use method thereof | 四川省帕提科斯能源科技有限公司 | 2021-03-12 | — | — | CN | claimed |
| US-20080054171-A1 | Target for Laser Desorption/Ionisation Mass Spectrometry | PHYSIKALISCHES BURO STEINMULLER GMBH | 2008-03-06 | — | — | US | claimed |
| CN-1249111-C | Prepn process of modified styrene-acrylic emulsion | UNIV JIANGHAN (CN) | 2006-04-05 | — | — | CN | claimed |
| US-20050090486-A1 | Trisubstituted pyrimidines | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2005-04-28 | — | — | US | claimed |
| CN-1486996-A | Prepn process of modified styrene-acrylic emulsion | 江汉大学 | 2004-04-07 | — | — | CN | claimed |
| US-20030134838-A1 | Trisubstituted pyrimidines | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2003-07-17 | — | — | US | claimed |
| JP-3086897-A | — | — | None | — | — | JP | disclosed |
| EP-4748941-A2 | NUCLEOSIDES AND NUCLEOTIDES WITH 3 -HYDROXY BLOCKING GROUPS | Illumina Cambridge Limited (GB) | 2026-05-27 | — | — | EP | disclosed |
| EP-3902814-B1 | NUCLEOSIDES AND NUCLEOTIDES WITH 3'-HYDROXY BLOCKING GROUPS AND THEIR USE IN POLYNUCLEOTIDE SEQUENCING METHODS | ILLUMINA CAMBRIDGE LTD (GB) | 2026-04-08 | — | — | EP | disclosed |
| US-20250236635-A1 | METHODS OF SEQUENCING USING NUCLEOTIDES WITH 3' ACETAL BLOCKING GROUP | ILLUMINA CAMBRIDGE LIMITED (GB) | 2025-07-24 | — | — | US | disclosed |
| US-20250146066-A1 | NUCLEOTIDES WITH A 3' AOM BLOCKING GROUP | ILLUMINA CAMBRIDGE LIMITED (GB) | 2025-05-08 | — | — | US | disclosed |
| US-12286453-B2 | Methods of sequencing using nucleotides with 3′ acetal blocking group | ILLUMINA CAMBRIDGE LIMITED (GB) | 2025-04-29 | — | — | US | disclosed |
| EP-0194545-A2 | Labelling of oligonucleotides | MOLECULAR DIAGNOSTICS, INC. (US) | 1986-09-17 | — | — | EP | disclosed |
| EP-0192197-A2 | Fast and specific immobilization of nucleic acids to solid supports | MOLECULAR DIAGNOSTICS, INC. (US) | 1986-08-27 | — | — | EP | disclosed |
| EP-0135587-A4 | DEFINED SEQUENCE SINGLE STRAND OLIGONUCLEOTIDES INCORPORATING REPORTER GROUPS, PROCESS FOR THE CHEMICAL SYNTHESIS THEREOF, AND NUCLEOSIDES USEFUL IN SUCH SYNTHESIS. | MOLECULAR BIOSYSTEMS INC (US) | 1986-04-02 | — | — | EP | disclosed |
| EP-0135587-A1 | DEFINED SEQUENCE SINGLE STRAND OLIGONUCLEOTIDES INCORPORATING REPORTER GROUPS, PROCESS FOR THE CHEMICAL SYNTHESIS THEREOF, AND NUCLEOSIDES USEFUL IN SUCH SYNTHESIS. | MOLECULAR BIOSYSTEMS INC (US) | 1985-04-03 | — | — | EP | disclosed |
| WO-1984003285-A1 | DEFINED SEQUENCE SINGLE STRAND OLIGONUCLEOTIDES INCORPORATING REPORTER GROUPS, PROCESS FOR THE CHEMICAL SYNTHESIS THEREOF, AND NUCLEOSIDES USEFUL IN SUCH SYNTHESIS | MOLECULAR BIOSYSTEMS INC (US) | 1984-08-30 | — | — | WO | disclosed |
| US-4154756-A | HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1979-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250146066-A1 | NUCLEOTIDES WITH A 3' AOM BLOCKING GROUP | NT5C3B, NSUN2, RNMT | ALDH1A1 899/4885SMN1; SMN2 3692/4885POLB 76/4885 |
| US-20030134838-A1 | Trisubstituted pyrimidines | APP, PSEN1, BACE1 | ALDH1A1 753/4885SMN1; SMN2 131/4885POLB 1630/4885 |
| US-20250236635-A1 | METHODS OF SEQUENCING USING NUCLEOTIDES WITH 3' ACETAL BLOCKING GROUP | RNGTT, NSUN2, NT5C3B | ALDH1A1 657/4885SMN1; SMN2 683/4885POLB 27/4885 |
| US-20050090486-A1 | Trisubstituted pyrimidines | APP, BACE1, PSEN1 | ALDH1A1 681/4885SMN1; SMN2 178/4885POLB 1148/4885 |
| US-12286453-B2 | Methods of sequencing using nucleotides with 3′ acetal blocking group | RNGTT, NSUN2, NT5C3B | ALDH1A1 640/4885SMN1; SMN2 756/4885POLB 25/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.